drugset

drugset / Trial / NCT01951066

Diabetic Macular Edema Treated With Ozurdex (DMEO)

NCT01951066 ↗

Phase 2 Completed 20 enrolled Johns Hopkins University

RandomizedCrossoverOpen-label

Summary

To measure various pro-permeability factors in the aqueous humor of patients with persistent/recurrent diabetic macular edema

Timeline

Start: 2013-10
Primary completion: 2015-12
Completion: 2015-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dexamethasone	Small molecule	—	Other

Indications